Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
26.51
-0.34 (-1.25%)
At close: May 14, 2025, 4:00 PM
26.50
0.00 (-0.02%)
After-hours: May 14, 2025, 4:00 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.75 billion as of May 14, 2025. Its market cap has decreased by -7.69% in one year.
Market Cap
1.75B
Enterprise Value
-1.93B
1-Year Change
-7.69%
Ranking
Category
Stock Price
$26.51
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.75B, a decrease of -6.10%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 1.77B | -2.40% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |